Launch week offerEnds in00h00m00s

annual Promonthly Pro

Carmen Bras Silva

Has grant

Assistant Professor

Faculty of Medicine of the University of Porto

Portugal

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Portugal

About

Carmen Bras Silva is an Assistant Professor at the Faculty of Medicine, University of Porto, Portugal. Her research focuses on the pathophysiology of cardiovascular diseases, particularly in relation to pulmonary arterial hypertension and its effects on right ventricular function. She has contributed to the understanding of various therapeutic potentials and mechanisms in cardiovascular health, evidenced by her recent publications on miR-146a, natriuretic peptides, and the KCNK3 potassium channel.

Recent Grants

Grant: Close

Relaxin-2 and Pulmonary Arterial Hypertension: pathophysiological role and therapeutic potential

Open Date: 2023-03-12

Close Date: 2024-09-11

Grant: Close

Health Research Network: From Lab to Community Health

Open Date: 2021-01-01

Close Date: 2025-12-31

Grant: Close

Epidermal growth factor receptor 4 activation in pulmonary arterial hypertension

Open Date: 2020-01-01

Close Date: 2022-12-01

Grant: Close

UnIC - Unidade de Investigação e Desenvolvimento Cardiovascular/ Cardiovascular Research and Development Center (UIDB/00051/2020)

Open Date: 2020-01-01

Close Date: 2024-12-01

Grant: Close

Cardiovascular Research and Development Center

Open Date: 2019-01-01

Close Date: 2019-12-31

Articles (23)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (20)

Frédéric Perros

Director of research

FRANCE

Carmen Bras Silva

Research Interests

Make your next move.

Explore related searches

About

Recent Grants

Articles (23)

Beta-3 Adrenoreceptor Agonist Mirabegron Improves Right Ventricular Function in a Rat Monocrotaline-Induced Pulmonary Hypertension Model.

One Health Insights into Pulmonary Hypertension: Bridging Human and Canine Medicine

Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunction.

Shifting from one-size-fits-all to an individualised VO2 plateau attainment

Biosensors for natriuretic peptides in cardiovascular diseases. A review

Unraveling the Impact of miR-146a in Pulmonary Arterial Hypertension Pathophysiology and Right Ventricular Function

The Ketone Bridge Between the Heart and the Bladder: How Fast Should We Go?

Corticotropin-releasing hormone and obesity: From fetal life to adulthood

Editorial: Therapeutics in pulmonary arterial hypertension

Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update

Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.

Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart

Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function—Preclinical Studies

Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives.

Aprender e Ensinar em Fisiologia

Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension

The thromboxane receptor antagonist <i>NTP42</i> promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload.

Candidate microRNAs as prognostic biomarkers in heart failure: A systematic review

Emerging Roles of Micrornas in Veterinary Cardiology

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers

Pulmonary Valve Replacement: A New Paradigm with Tissue Engineering

Urocortins as biomarkers in cardiovascular disease

Kcnk3 Dysfunction Exaggerates The Development Of Pulmonary Hypertension Induced By Left Ventricular Pressure Overload.

Collaborators (20)

Frédéric Perros

Ana Patrícia Fontes-Sousa

Marion Delcroix

Peter Pokreisz

Bastien Masson

Vera Isca

Rozenn Quarck

Francisco Perez-Vizcaino

Gregoire Ruffenach

Susana Silva

Fabrice Antigny

Ana Cláudia Santos Pereira

sebastien bonnet

João Paulo Brito

Gabriela Costa

Mariana Sousa

Telmo Pereira

Luís Monteiro Rodrigues

Paulo Moura Relvas de Sousa e Silva

Pedro Ferreira

Make your next move.